Position in BEAM
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$786
New position
Shares Held
33
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vanguard National Trust Co holds $396,472 across 10 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256 | $159,626 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
294 | $146,038 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
1,000 | $57,220 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
|
597 | $10,101 | |
| 5 | MRNA |
Moderna, Inc.
|
98 | $6,862 | |
| 6 | BNTX |
BioNTech SE
|
61 | $5,676 | |
| 7 | FTRE |
Fortrea Holdings Inc.
|
302 | $5,254 | |
| 8 | INSM |
INSMED Inc
|
29 | $3,091 |
All Filings in BEAM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $786 | 33 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||